|
Report Date : |
10.10.2014 |
IDENTIFICATION DETAILS
|
Correct Name : |
TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY |
|
|
|
|
Registered Office : |
4042 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
28.12.1989 |
|
|
|
|
Com. Reg. No.: |
13 10 040145 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical preparations |
|
|
|
|
No of Employees : |
2988 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Hungary |
B1 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
HUNGARY - ECONOMIC OVERVIEW
Hungary has made the transition
from a centrally planned to a market economy, with a per capita income nearly
two-thirds that of the EU-28 average. In late 2008, Hungary's impending
inability to service its short-term debt - brought on by the global financial
crisis - led Budapest to obtain an IMF/EU/World Bank-arranged financial
assistance package worth over $25 billion. The global economic downturn,
declining exports, and low domestic consumption and fixed asset accumulation,
dampened by government austerity measures, resulted in a severe economic
contraction in 2009. In 2010 the new government implemented a number of changes
including cutting business and personal income taxes, but imposed "crisis
taxes" on financial institutions, energy and telecom companies, and
retailers. The IMF/EU bail-out program lapsed at the end of the year and was
replaced by Post Program Monitoring and Article IV Consultations on overall
economic and fiscal processes. At the end of 2011 the government turned to the
IMF and the EU to obtain financial backstop to support its efforts to refinance
foreign currency debt and bond obligations in 2012 and beyond, but Budapest's
rejection of EU and IMF economic policy recommendations led to a breakdown in
talks with the lenders in late 2012. Global demand for high yield has since
helped Hungary to obtain funds on international markets. Hungary’s progress
reducing its deficit to under 3% of GDP led the European Commission in 2013 to
permit Hungary for the first time since joining the EU in 2004 to exit the Excessive
Deficit Procedure.
|
Source
: CIA |
TEVA GYÓGYSZERGYÁR
ZÁRTKÖRÛEN MÛKÖDÕ RÉSZVÉNYTÁRSASÁG
4042 Debrecen, Pallagi út
13.
Phone: +36(52)515100
Telefax: +36(52)515142
E-Mail: maria.dioszegi@teva.hu
Web: www.teva.hu
Legal form joint stock
company
Established on 28/12/1989 - joint
stock company
1951 - State-owned
company
Legal
predecessor:
BIOGAL
Gyógyszergyár Transformation
Statistical
number:
4000 Debrecen,
Pallagi út 13.
TEVA Magyarország
Gyógyszerforgalmazó Merging
Zártkörûen Mûködõ
Részvénytársaság
RegNr.: 13 10
040145
Statistical
number: 10798982
2100 Gödöllõ,
Repülõtéri út 5.
Registered on 29/12/1989,
Hajdú-Bihar megye, RegNr.: 09 10 000016
Tax number:
10318353-2-09
EU Community VAT
identification number: HU10318353
Statistical
number: 10318353
Last entry:
2014.08.07.
Events, General
events:
negative data 13.06.2006 -
Residence change
Court: Hajdú-Bihar
megye
Firm Journal
reference: 2006/27 (06.07.2006)
Registered
HUF
4 539 293 480,-
capital
Shareholder TEVA
Pharmaceuticals Europe B.V.
Computerweg 10.,
3542 Utrecht,
Netherlands
Shareholder with
majority
significance
Beginning of
validity: 10.07.2014
Person in charge
for delivery:
Andréko Kinstellar
Ügyvédi Iroda
1054 Budapest,
Széchenyi rakpart 3.
Names of the
other shareholders
are not known
Authorized to Glenn Boling
Benjamin
sign (Mothers name: Gay
Gilbreath)
CanyonMalabar road
28661., 92679 Trabuco, USA
member of the
board
authorized to
collective sign
Beginning of legal
relation: 03.06.2014
End of legal
relation: 31.05.2019
Beginning of validity: 03.06.2014
Person in charge
for delivery:
Andréko Kinstellar
Ügyvédi Iroda
1054 Budapest,
Széchenyi rakpart 3.
Lustig David
(Mothers name:
Rachel Presenty)
TiqvaBasel street
5., 49131 Petah, Island
member of the
board
authorized to
collective sign
Beginning of legal
relation: 16.06.2014
End of legal
relation: 31.05.2019
Beginning of
validity: 16.06.2014
Person in charge
for delivery:
Andréko Kinstellar
Ügyvédi Iroda
1054 Budapest,
Széchenyi rakpart 3.
Mika Petteri
Kayhkö Kai
(Mothers name:
Pirilla Hilkka Helena)
Telamaaentie 16A.,
02170 Espoo, Finland
member of the
board
authorized to collective sign
Beginning of legal
relation: 03.06.2014
End of legal
relation: 31.05.2019
Beginning of
validity: 03.06.2014
Person in charge
for delivery:
Andréko Kinstellar
Ügyvédi Iroda
1054 Budapest,
Széchenyi rakpart 3.
Mikucki
Maciej
(Mothers name:
Aleksandra Jezewska)
ul. Bruna 9/195,
02-594 Varsó, Poland
member of the
board
authorized to
collective sign
Beginning of legal
relation: 30.03.2014
End of legal
relation: 31.05.2017
Beginning of
validity: 30.03.2014
Person in charge
for delivery:
Dr. Eszter
Török
1023 Budapest,
Borbolya utca 11.
Yehiel Levin
Yossef
(Mothers name:
Loni Reich-Levin)
Basel street 5.,
49131 Petah Tiqva, Island
member of the
board
authorized to collective sign
Beginning of legal
relation: 27.05.2013
End of legal
relation: 31.05.2016
Beginning of
validity: 27.05.2013
Person in charge
for delivery:
Dr. Helga
Földi
4024 Debrecen,
Teleki utca 34. I. em. 3.
Csaba Sasvári
(Mothers name:
Sövér Teréz)
7150 Bonyhád,
Perczel kert 6.
Employee
authorized to
sign
Beginning of
validity: 24.05.2012
Supervisory de Notaristefani
di Vastogirar Carlo
Board (Mothers name:
Luisa Barone)
lakeChesnut ridge
road 400., 07677 Woodcliff, USA
member of the
supervisory board
Beginning of legal
relation: 31.12.2013
End of legal
relation: 31.05.2016
Beginning of validity: 31.12.2013
Person in charge
for delivery:
Dr. Helga
Földi
4024 Debrecen,
Teleki utca 24. 1. em. 3.
Dr. Lajos
Hegedûs
(Mothers name:
Kiss Gizella)
1029 Budapest,
Tompa Mihály utca 15
member of the
supervisory board
Beginning of legal
relation: 22.06.2012
End of legal
relation: 31.05.2015
Beginning of
validity: 22.06.2012
Erzsébet Sas
(Mothers name:
Jenei Erzsébet)
4033 Debrecen,
Sólyom utca 83-85.
member of the
supervisory board
Beginning of legal
relation: 03.06.2014
End of legal
relation: 31.05.2017
Beginning of
validity: 03.06.2014
Auditor
PricewaterhouseCoopers
Könyvvizsgáló Korlátolt
Felelõsségû
Társaság
1055 Budapest,
Bajcsy-Zsilinszky
út 78.
Szûcs Márta
Hegedûsné
2071 Páty,
Várhegyi utca 6.
General data Main
activity: Code: Insolvency
Észak- Hajdú-
Manufacture of
pharmaceutical (2120.) risk: alföldi
Bihar:
preparations 3,23 % régió: 50,00 %
33,33 %
Brand name:
ALLITHERA,
ALUSULIN, ASTRIX, AUGMENTIN , BRONCHO-VAXOM,
BRULAMYCIN,
CONTRAMAL, CRUPODEX, DICYNONE,
DOXIUM, ERYC,
HEVIZOS, ISOPRINOSINE, MARIPEN, NEOGRANORMON,
OXYBION,
PALLAGICIN, PENGLOBE, PEPONEN
REVALID, SPUTOPUR, TILCOTIL, ULCERAN, VEGACILLIN
Former name:
BIOGÁL
Gyógyszergyár Rt.
BIOGAL
Gyógyszergyár Részvénytársaság
TEVA Gyógyszergyár
Rt.
TEVA Gyógyszergyár
Részvénytársaság
Full name:
TEVA Gyógyszergyár Zártkörûen Mûködõ
Részvénytársaság
Name in foreign
language:
TEVA
Pharmaceutical Works Private Limited Company
TEVA Pharmaceuticals
Ltd.
Short name:
TEVA Gyógyszergyár
Zrt.
Export:
Belgium
Israel
Netherlands
Switzerland
USA
Import:
Germany
Israel
Netherlands
USA
General
contacts:
Phone:
+36(52)515100
+36(52)515040
+36(52)515200
Telefax:
+36(52)515142
+36(52)418752
+36(52)515072
E-Mail:
maria.dioszegi@teva.hu
Web:
www.teva.hu
Residence
address:
4042 Debrecen,
Pallagi út 13.
Address of the company premises:
4030 Debrecen,
Vámraktár utca 3.
Branch
establishment:
2100 Gödöllõ,
Táncsics Mihály u. 82.
3792 Sajóbábony,
024/180.
2100 Gödöllõ,
Repülõtéri út 5.
2100 Gödöllõ, Liget
utca 2.
1074 Budapest,
Rákóczi út 70-72.
4400 Nyíregyháza,
Tünde utca 9.
8000
Székesfehérvár, Seregélyesi utca 129.
6640 Csongrád,
Kenderföldek utca 3.
9730 Kõszeg,
Malomárok utca 2.
7634 Pécs, Makay
István utca 13/A.
3800 Szikszó,
049/1.
The company has
ISO 9001 quality certificate.
Regular
activity:
Producing and
distributing of basic
materials,
different kind of
medicines (human,
veterinary)
healthgiving products
TEÁOR 2008 (NACE
rev. 2): Code: Insolvency
Észak- Hajdú-
risk: alföldi Bihar:
régió:
Manufacture of
other food (1089.) 4,43 % 0,00 %
0,00 %
products
n.e.c.
Manufacture of
other inorganic (2013.) 4,88 % 0,00 %
0,00 %
basic
chemicals
Manufacture of
other organic (2014.) 2,13 % 0,00 %
0,00 %
basic chemicals
Manufacture of
pesticides and (2020.) 2,27 % 0,00 %
0,00 %
other agrochemical
products
Manufacture of
soap and (2041.) 4,76 % 0,00 %
0,00 %
detergents,
cleaning and
polishing
preparations
Manufacture of
perfumes and (2042.) 1,68 % 0,00 %
0,00 %
toilet
preparations
Manufacture of
other chemical (2059.) 1,54 % 0,00 %
0,00 %
products
n.e.c.
Manufacture of
basic (2110.) 3,23 % 0,00 %
0,00 %
pharmaceutical
products
Agents specialised
in the sale (4618.) 4,77 % 7,59 %
4,23 %
of other
particular products
Wholesale of
pharmaceutical (4646.) 2,71 % 11,36 %
8,00 %
goods
Non-specialised
wholesale trade (4690.) 4,82 % 5,59
% 2,63 %
Dispensing chemist
in (4773.) 1,85 % 0,32 %
0,00 %
specialised
stores
Retail sale of medical and (4774.) 2,87 % 2,86 %
0,00 %
orthopaedic goods
in
specialised
stores
Computer
programming activities (6201.) 1,69 %
2,22 % 1,43 %
Computer
consultancy activities (6202.) 1,86 %
3,49 % 1,20 %
Other information
technology (6209.) 3,36 % 4,08 %
5,26 %
and computer service
activities
Renting and
operating of own (6820.) 2,03 % 2,03 %
2,95 %
or leased real
estate
Accounting,
bookkeeping and (6920.) 1,56 % 1,34 %
1,80 %
auditing
activities; tax
consultancy
Technical testing
and analysis (7120.) 2,62 % 1,92 %
1,54 %
Research and
experimental (7211.) 1,69 % 2,38 %
2,78 %
development on
biotechnology
Other research
and (7219.) 1,37 % 0,68 %
0,91 %
experimental
development on
natural sciences
and
engineering
Market research
and public (7320.) 3,56 % 3,28 %
4,00 %
opinion
polling
Other
professional, scientific (7490.) 2,41
% 3,08 % 0,60 %
and technical activities n.e.c.
Other business
support service (8299.) 4,35 % 5,33 %
6,11 %
activities
n.e.c.
Employees 2007 2106 employees
2008 1946 employees
2009 2001 employees
2010 2090 employees
2011 2384 employees
2012 2513 employees
2013 2543 employees
06/01/ 2604 employees
2014
27/01/ 2604 employees
2014
27/02/ 2581 employees
2014
10/03/ 3099 employees
2014
07/04/ 3093 employees
2014
07/05/ 3082 employees
2014
04/06/ 3050 employees
2014
04/07/ 3016 employees
2014
05/08/ 3005 employees
2014
04/09/ 2980 employees
2014
05/09/ 2988 employees
2014
Annual turnover 2004
Net income HUF 86 029 000 000,-
2005 Net income HUF
91 770 000 000,-
2006 Net income HUF
125 764 000 000,-
2007 Net income HUF
99 439 000 000,-
2008 Net income HUF
100 036 000 000,-
2009 Net income HUF
105 553 000 000,-
2010 Net income HUF
125 372 000 000,-
2011 Net income HUF
156 125 000 000,-
2012 Net income HUF
188 438 000 000,-
2013 Net income HUF
150 724 000 000,-
Property Company's
property: Technological equipments, machines, vehicles
Book value:
57 394 000 000,- HUF (According to balance - 2013)
Company's
property:
property
Book value:
39 344 000 000,- HUF (According to balance - 2013)
The enclosed profit and loss account of 2013 is originated
from official
source, it is authenticated by the auditor .
(31.12.2013 -
1000000 HUF)
The enclosed
profit and loss account of 2012 is originated
from official
source, it is authenticated by the auditor .
(31.12.2012 -
1000000 HUF)
The enclosed
profit and loss account of 2011 is originated
from official source, it is
authenticated by the auditor .
(31.12.2011 -
1000000 HUF)
The enclosed
profit and loss account of 2010 is originated
from official
source, it is authenticated by the auditor .
(31.12.2010 -
1000000 HUF)
The enclosed
balance of 2013 is originated from official
source, it is authenticated
by the auditor . (31.12.2013 -
1000000 HUF)
The enclosed
balance of 2012 is originated from official
source, it is authenticated
by the auditor . (31.12.2012 -
1000000 HUF)
The enclosed
balance of 2011 is originated from official
source, it is
authenticated by the auditor . (31.12.2011 -
1000000 HUF)
The enclosed
balance of 2010 is originated from official
source, it is
authenticated by the auditor . (31.12.2010 -
1000000 HUF)
Interests TEVA Gyógyszergyár
Zártkörûen Mûködõ Részvénytársaság
(Statistical
number: 10318353):
CEF INVEST
Szolgáltató Korlátolt Owner
Felelõsségû
Társaság (Statistical
number:
11693859)
*** Last event influencing the
credit risk: 2012.12.27. ***
EL-TECH 93.
Elektrotechnikai, Owner
Szolgáltató és
Karbantartó
Korlátolt Felelõsségû Társaság
(Statistical
number: 11150460)
IPENERG Ipari
Energiafogyasztók Members
Érdekképviselete
Egyesülés
végelszámolás
alatt (Statistical
number:
22692144)
*** Last event
influencing the credit risk: 2013.08.01. ***
Pliva Hungária
Kereskedelmi és Owner
Szolgáltató
Korlátolt Felelõsségû
Társaság
(Statistical number:
10867091)
*** Last event
influencing the credit risk: 2013.11.22. ***
TEVA Service
Holding Korlátolt Owner
Felelõsségû
Társaság (Statistical
number:
14541878)
*** Last event
influencing the credit risk: 2013.09.20. ***
TRANS-BIOGAL
Fuvarozó, Owner
Kereskedelmi és
Szolgáltató
Korlátolt
Felelõsségû Társaság
(Statistical number: 11150185)
*** Last event
influencing the credit risk: 2014.02.19. ***
Vezér Patika
Gyógyszer- Owner
kereskedelmi
Korlátolt Felelõsségû
Társaság
(Statistical number:
14111608)
*** Last event
influencing the credit risk: 2012.12.27. ***
Bank relations CIB Bank
Zrt.Debrecen I.Fiók:
Central address:
HU Debrecen, Piac u. 1-3.
Account number:
107001410206290952300002
CIB Bank Zrt.
Gödöllõi fiók:
Central address:
HU Gödöllõ, Szabadság tér 16-17.
Account number:
107001960206290952200005
MKB Bank
Zrt.:
Central address:
HU Budapest, Váci utca 38.
Account number:
103000023460302400003285
CIB Bank Zrt.Debrecen I.Fiók:
Central address:
HU Debrecen, Piac u. 1-3.
Account number:
107001410206290952200005
Account number:
107001410206290951100005
Citibank Europe
Plc. Mo-i Fióktelepe:
Central address:
HU Budapest, Szabadság tér 7.
Account number:
108000071100104300000000
MKB Bank
Zrt.:
Central address:
HU Budapest, Váci utca 38.
Account number:
103000023460302470073285
Citibank Europe
Plc. Mo-i Fióktelepe:
Central address:
HU Budapest, Szabadság tér 7.
Account number:
108000071100110800000000
Account number:
108000077100115900000000
Account number:
108000078100116700000000
Account number:
108000079100117500000000
MKB Bank
Zrt.:
Central address:
HU Budapest, Váci utca 38.
Account number:
103000023460302449020140
Citibank Europe
Plc. Mo-i Fióktelepe:
Central address:
HU Budapest, Szabadság tér 7.
Account number:
108000070100118300000000
Account number:
108000071100119100000000
Account number:
108000071100125600000000
Account number:
108000073100127200000000
MKB Bank
Zrt.:
Central address:
HU Budapest, Váci utca 38.
Account number:
103000023460986200003285
CIB Bank
Zrt.Debrecen I.Fiók:
Central address:
HU Debrecen, Piac u. 1-3.
Account number:
107001410206290951200002
BNP-Paribas
Magyarországi fióktelepe:
Central address:
HU Budapest, Széchenyi István tér 7-8.
Account number:
131000070250680000689781
Account number:
131000070250680000683486
Account number:
131000070250680000688405
OTP Észak-alföldi
r., Debrecen:
Central address: -
Debrecen, Hatvan u. 2-4.
Account number:
117380082087922000000000
Citibank Europe
Plc. Mo-i Fióktelepe:
Central address:
HU Budapest, Szabadság tér 7.
Account number:
108000070617202400000000
Account number:
108000077617208300000000
Account number:
108000077617208300000000
Account number:
108000076100129900000000
Company constant
(31)
development
Business course good
(21)
Terms of without
compliants, supplier feedback show no (39)
payment negative data
Business The establishing
of the busness connection is
(21)
connection allowed
Number of <table
width="400"><tr><td>Duration</td><td>Queries</td></
queries tr><tr><td>4
weeks</td><td>0</td></tr><tr><td>4 - 8
weeks</
td><td>0</td></tr><tr><td>8 weeks - 12
months</td><td>3</td></
tr></table>
Credit rating According to the
survey the non-payment risk
class status
can be minimized in light of he solvency index.
Solvency index Credit risk Rating No payment
default risk
within a year
000 none unknown
100-149 none excellent 0,01%
solvency
150-200 minimal very good 0,22%
solvency
201-250 acceptable good solvency 0,49%
251-300 acceptable medium solvency 1,50%
301-350 average poor solvency 3,56%
351-499 big not 7,17%
satisfactory
solvency
500 significant business
relations not
recommended
600 relations to
be declined
A. The enclosed balance of 2010 is originated from official source, it
is
authenticated by the auditor . (31.12.2010 - 1000000 HUF)
B. The enclosed balance of 2011 is originated from official source, it
is
authenticated by the auditor . (31.12.2011 - 1000000 HUF)
C. The enclosed balance of 2012 is originated from official source, it is
authenticated by the auditor . (31.12.2012 - 1000000 HUF)
D. The enclosed balance of 2013 is originated from official source, it
is
authenticated by the auditor . (31.12.2013 - 1000000 HUF)
balance
A B C D
2010.12.31. 2011.12.31. 2012.12.31. 2013.12.31.
>FIXED
ASSETS
>283 050
>347 466
>324 074 >424 342
>Intangible
assets >32 786 >32 570 >33 775 >35 822
Capitalised
value of
0
fundantion
and
restructuring
costs
Capitalised
value of 25 933 26 837 29 356 31 275
research
and development
costs
Consessions
and similar 3 517 2 856 2 131 1 749
rights
and assents
Intellectual
property 740 930 988 2 147
Goodwill 2 596 1 947 1 300 651
Advance
payments on on
0
intangible
assets
Revaluation
of intangible 0
assets
>Tangible
assets >70 456 >95 577 >111 020 >117 675
Land
and buildings and
25 899 30 220 33 615 39 344
related
concessions and
similar
rights
Technical
equipment, 25 625 33 999 47 457 57 394
machinery
and vehicles
Other
equipment, fittings
1 190 1 284 1 303 1 727
and
vehicles
Breeding
stock
0
Capital
WIP, renovations 14 728 26 149 28 515 19 192
Advance
payments on 3 014 3 925 130 18
Capital
WIP
Revaluation
of tangible 0
assets
>Financial
investments >179 808 >219 319 >179 279 >270 845
Long
term investments in
169 011 24 073 5
94 960
related
companies
Long
term loans given to
10 614 0
related
companies
Other
long term 29 194 980 178 983 174 722
investments
Long
term loans given to
0
other
investees
Other
loag term loans 154 266 291 1 163
given
Securities
representing 0
long
term loans
Revaluation
of financial
0
investments
>CURRENT
ASSETS
>294 315
>409 152
>446 556
>544 341
>Inventories >47 958 >66 749 >84 789 >80 646
Raw
materials and
25 220 39 176 49 512 33 870
consumables
Work
in progress and semi-
16 006 19 524 22 784 22 208
finished
products
Animals
0
Finished
goods 6 564 7 869 12 233 12 589
Goodss,
services 168 179 254 11 925
Advance
payments on
1 6 54
inventories
>Receivables >236 173 >329 939 >351 725 >453 226
Trade
accounts receivable
1 614 2 396 2 489 13 910
Receivables
from related 116 417 276 209 346 317 434 895
companies
Receivables
from other 1 1 0
investees
Bills
of exchange
0
receivable
Other
receivables
118 141 51 333 2 919 4 421
Revaluation
difference on 0
receivables
Revaluation
difference (+
0
)
on derivative
transactions
>Securities >6 277 >7 240 >6 643 >164
Investments
in related 6 246 7 206 6 614 0
companies
Other
investments
0
Own
shares, own quotas
0
Securities
personifying 31 34 29 164
circulational
credit
relation
aim
>Liquid
assets
>3 907
>5 224
>3 399 >10 305
Cash
in hand, cheques 2 1 3 5
Bank
deposits
3 905 5 223 3 396 10 300
>PREPAID
EXPENSES AND
>1 702
>2 993
>13 261 >11 813
ACCRUED
INCOME
Accrued
income 1 415 2 660 12 715 11 020
Prepaid
expenses 287 333 546 793
Deferred
expenses 0
>TOTAL
ASSETS
>579 067
>759 611
>783 891 >980 496
>SHAREHOLDERS'
EQUITY >396 231 >464 493 >487 085 >534 214
Capital
subscribed 4 390 4 390 4 390 4 539
thereof:
treasure shares
0
repurchased
at face value
Issued
but not paid 0
capital
(-)
Capital
reserves 9 9 9 37 685
Retained
earnings from 304 506 364 995 430 737 439 351
previous
years
Non-distributable
reserves 25 933 26 837 29 356 31 245
Revaluation
reserve
0
Profit
per balance-sheet 61 393 68 262 22 593 21 394
>PROVISIONS >2 359 >2 027 >2 340 >725
Provisions
for expected 1 909 1 647 2 014 474
liabilities
Provisions
for future 450 380 326 251
expenses
Other
provision
0
>LIABILITIES >166 223 >271 292 >266 980 >417 828
>Subordinated
liabilities
>0 >0
Subordinated
liabilities
0
to
related companies
Subordinated
liabilities
0
to
ither investees
Subordinated
liabilities
0
to
other enterprises
>Long
term liabilities
>86 818
>98 861
>35 504 >36 138
Long
term credits 101 71 0
Convertible
bonds
0
Debts on the issue of
0
bonds
Investment
and 0
development
loans
Other
long term loans
86 717 98 790 35 504 36 138
Long
term liabilities to 0
related
companies
Long
term liabilities to
0
other
investees
Other
long term
0
liabilities
>Short
term liabilities
>79 405
>172 431
>231 476 >381 690
Short
term loans 26 30
54 952 0
thereof:
convertible bonds
0
Short
term credits
5
Advance
payments received 6 0
from
customers
Trade
accounts payable
7 402 13 577 10 131 11 925
Bills
of exchange payable
0
Short
term liabilities to
71 857 158 156 100 346 311 018
related
companies
Short
term liabilities to 57 40 27 27
other
investees
Other
short term 63 628 66 014 58 715
liabilities
Revaluation
difference on
0
liabilities
Revaluation
difference
0
(–)
on derivative
transactions
>ACCRUED
EXPENSES AND
>14 254
>21 799
>27 486 >27 729
DEFERRED
INCOME
Deferred
revenues 1 944 1 583 1 283
Accrued
expenses and 10 827 19 131 22 892 23 072
deferred
income
Deferred
income 1 483 2 668 3 011 3 374
>TOTAL
LIABILITIES AND
>579 067
>759 611
>783 891
>980 496
A. The enclosed profit and loss account of 2010 is originated from
official
source, it is authenticated by the auditor . (31.12.2010 - 1000000
HUF)
B. The enclosed profit and loss account of 2011 is originated from
official
source, it is authenticated by the auditor . (31.12.2011 - 1000000
HUF)
C. The enclosed profit and loss account of 2012 is originated from
official
source, it is authenticated by the auditor . (31.12.2012 - 1000000
HUF)
D. The enclosed profit and loss account of 2013 is originated from
official
source, it is authenticated by the auditor . (31.12.2013 - 1000000
HUF)
profit
and loss account A B C D
2010.12.31.
2011.12.31. 2012.12.31. 2013.12.31.
Net
domestic sales
13 811 21 438 14 913 12 098
revenues
Net
export sales revenues
111 561 134 687 173 525 138 626
>Net
sales revenues
>125 372
>156 125
>188 438 >150 724
Change
in self- -852
4 823 7 624 -314
manufactured
inventories
Capitalised
value of self- 10 358 8 265 14 935 13 255
manufactures
assets
Capitalised
value of own 9 506 13 088 22 559 12 941
performance
Other
revenues
20 349 6 648 16 895 72 055
of
which: reversal of
3 43 0
impairment
loss provision
Cost
of raw materials
48 937 68 506 85 819 74 747
Value
of services used 25 347 24 156 27 101 28 992
Value
of other services
1 126 1 273 1 951 2 116
Cost
of goods sold
1 114 881 1 704 5 045
Value
of recharged
3 171 784 1 487 873
services
>Material
type expenditure >79 695 >95 600 >118 062 >111 773
Wages 9 179 10 420 11 792 12 581
Other
payments to
1 862 2 606 2 035 2 290
personnel
Personnel
related 2 860 3 351 3 748 3 952
contributions
>Payments
to personnel >13 901 >16 377 >17 575 >18 823
Deprecation
change 8 778 7 039 8 521 9 704
Other
expenses
26 968 30 151 63 994 79 342
of
which: impairment loss
4 540 774 6 487 387
provision
TRADING
PROFIT 25 885 26 694 19 740 16 078
Dividend
received 9 47 11 720
of
which: received from 9 709
related
companies
Gain
on sale of investment
4 421 3 261
Given
to associated
4 421 3 261
company
Interest
received and 381 184 10 6
gain
on financial
transactions
of
which: received from 315 176 0
related
companies
Other
interest received
1 813 1 968 2 593 5 130
of
which: received from
1 739 1 950 2 573 5 100
related
companies
Other
revenues from
125 851 111 637 90 673 49 322
financial
transactions
Revenues
from financial 128 054 113 836 97 708 58 439
transactions
Losst
on financial
0
investments
of
which: given to 0
related
companies
Interest
paid 1 618 2 352 1 937 6 127
of
which: given to 156 514 383
5 494
related
companies
Impairment
loss of 1 0
financial
investment,
secunties
and bank
deposits
Other
expenditures on
90 751 69 849 91 958 46 723
financial
transactions
Expenditures
of financial 92 370 72 201 93 895 52 850
transactions
FINANCIAL
PROFIT 35 684 41 635 3 813 5 589
PROFIT
FROM ORDINARY 61 569 68 329 23 553 21 667
BUSINESS
Extraordinary
revenues 162 219 193 278
Extraordinary
expenditures 58 54 657 192
PROFIT
ON EXTRAORDINARY 104 165 -464 86
EVENTS
>NET
PROFIT BEFORE
>61 673
>68 494 >23 089 >21 753
TAXATION
Tax
liability 280 232 496 359
>AFTER
TAX PROFIT
>61 393
>68 262
>22 593 >21 394
Dividends
paid out of
0
accumulated
profit reserve
Dividends
paid (approved)
0
out
of current year
profits
>NET
PROFIT PER BALANCE
>61 393
>68 262
>22 593 >21 394
SHEET
Ratios 2010 2011
2012 2013
Equity ratio 0,68 0,61
0,62 0,54
Cleared equity ratio 0,68
0,61 0,62 0,54
Current liquidity 3,71 2,37
1,93 1,43
Quick liquidity 3,1 1,99
1,56 1,21
Working capital 214910000000 236721000000 215080000000
162651000000
Gearing 0,42 0,58
0,55 0,78
Cleared gearing 0,22 0,21
0,19 0,07
Profitability 49,19 43,87
12,25 14,43
Operating profitability 20,65
17,1 10,48 10,67
Stock days 140 156
164 195
Debtor days 688 771
681 1098
Supplier days 33,9
51,84 31,32 38,94
equity ratio (%) 68,43 61,15
62,14 54,48
Long term debt ratio n/a
n/a n/a n/a
(%)
Leverage (%) 40,07 55,35
39,18 64,99
Coverage of fixed 171 162
161 134
assets (%)
Receivables turnover 344
651 676 1087
ratio (day)
P/L after tax/Turnover 20,65
17,1 10,48 10,67
(%)
Return On Investment 0,05
0,04 0,03 0,02
Interest cover 16 11,35
10,19 2,62
Return On Equity (%) 15,49
14,7 4,64 4
Return On Assets (%) 10,6
8,99 2,88 2,18
Net income/Turnover (%) 48,97
43,72 11,99 14,19
Change in Turnover (%) 18,78
24,53 20,7 -20,01
Change in Net income 9,41
31,18 3,2 25,08
(%)
Debtors/Creditors 0,22 0,18
0,25 1,17
Change in P/L before 604
3,13 -26,05 -18,55
tax (%)
Turnover 125372000000 156125000000
188438000000 150724000000
Turnover/Employees 49300826 61394023 74100669 59270153
Share capital 396231000000 464493000000
487085000000 534214000000
Advertisement The database which was published in
HVG on 09.11.2013 and
16.11.2013 of the ”TOP 500
Hungarian companies regarding the
revenues and after-tax
profit” and another one which was also
published in HVG on
27.07.2013 of the ”TOP 50 The biggest
Hungarian companies
regarding the revenues, export revenues,
after-tax profit,
number of employees and equity” were
compiled. by examining the
data of not
less than 8.500 companies
(from official sources and the firms
themselves).
Legal agreement This information is addressed exclusively to addresse.
We don't assume responsibility for negligence referring to the content of this
information. On behalf of the objective
information, please inform us if you have different observations.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.04 |
|
|
1 |
Rs.98.64 |
|
Euro |
1 |
Rs.77.74 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
SMN |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.